Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 2C receptor (5-HT2C) is a G protein-coupled receptor (GPCR) primarily expressed within the central nervous system. Upon activation by serotonin, it couples to Gq proteins, activating PLC, IP3, and Ca2+ signaling. It plays a critical role in regulating appetite, mood, locomotion, and endocrine function. Due to its involvement in key CNS processes, it represents a therapeutic target for obesity, psychiatric disorders, and substance use disorders. Drug development is complicated by cross-reactivity with other 5-HT2 receptor subtypes.
Agonist binding leads to activation of Gq proteins, phospholipase C (PLC), IP3 production, and intracellular Ca2+ release. Also activates phospholipase A2 (PLA2), RhoA/PLD pathway, and extracellular signal-regulated kinase (ERK) pathway.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 2C Receptor (5-HT2C).